Patents Assigned to Optime Therapeutics, Inc.
  • Publication number: 20090196914
    Abstract: The present invention provides liposomal L-carnitine formulations and methods for the treatment of intermittent claudication. The formulation is optimized with respect to L-carnitine transport through skin in vitro. Preferably, the formulation is a topical cream for the administration of the drug directly on the muscle group that is most affected by the poor local blood flow.
    Type: Application
    Filed: July 23, 2008
    Publication date: August 6, 2009
    Applicant: OPTIME Therapeutics, Inc.
    Inventor: Hans E.J. Hofland
  • Publication number: 20050196435
    Abstract: A new method of producing liposomes is described using an in-line mixing system. The liposomes produced by this method find utility in numerous therapeutic applications.
    Type: Application
    Filed: January 5, 2005
    Publication date: September 8, 2005
    Applicant: Optime Therapeutics, Inc.
    Inventors: Martin Baker, William Heriot
  • Publication number: 20050095281
    Abstract: The present invention provides liposomal formulations comprising a lipid vesicle and at least one single chain lipid active agent. In addition, the present invention provides methods for using the same for preventing an infection in a mammal.
    Type: Application
    Filed: March 12, 2004
    Publication date: May 5, 2005
    Applicants: OPTIME Therapeutics, Inc., Megee-Womens Health Corporation
    Inventors: Hans Hofland, Lisa Rohan
  • Patent number: 6855296
    Abstract: A new method of producing liposomes is described using an in-line mixing system. The liposomes produced by this method find utility in numerous therapeutic applications.
    Type: Grant
    Filed: November 12, 1999
    Date of Patent: February 15, 2005
    Assignee: Optime Therapeutics, Inc.
    Inventors: Martin T. Baker, William A. Heriot
  • Patent number: 6855277
    Abstract: A new method of producing liposomes is described using an in-line mixing system. The liposomes produced by this method find utility in numerous therapeutic applications.
    Type: Grant
    Filed: November 15, 2002
    Date of Patent: February 15, 2005
    Assignee: Optime Therapeutics, Inc.
    Inventors: Martin T. Baker, William A. Heriot
  • Publication number: 20040224010
    Abstract: The present invention provides, inter alia, novel, liposome-based formulations for enhanced ophthalmic drug delivery. Such ophthalmic drug formulations are useful for treating ocular inflammation stemming from, for example, iritis, conjunctivitis, seasonal allergic conjunctivitis, acute and chronic endophthalmitis, anterior uveitis, uveitis associated with systemic diseases, posterior segment uveitis, chorioretinitis, pars planitis, masquerade syndromes including ocular lymphoma, pemphigoid, scleritis, keratitis, severe ocular allergy, corneal abrasion, or blood-aqueous barrier disruption, and for treating post-operative ocular inflammation, resulting from, for example, photorefractive keratectomy, cataract removal surgery, intraocular lens implantation or radial keratotomy.
    Type: Application
    Filed: November 13, 2003
    Publication date: November 11, 2004
    Applicant: OPTIME Therapeutics, Inc.
    Inventors: Hans Hofland, Juiiet Bongianni, Tobias Wheeler
  • Publication number: 20030124033
    Abstract: A new method of producing liposomes is described using an in-line mixing system. The liposomes produced by this method find utility in numerous therapeutic applications.
    Type: Application
    Filed: November 15, 2002
    Publication date: July 3, 2003
    Applicant: OPTIME Therapeutics, Inc.
    Inventors: Martin T. Baker, William A. Heriot
  • Patent number: 6534018
    Abstract: A new method of producing liposomes is described using an in-line mixing system. The liposomes produced by this method find utility in numerous therapeutic applications.
    Type: Grant
    Filed: November 12, 1999
    Date of Patent: March 18, 2003
    Assignee: Optime Therapeutics, Inc.
    Inventors: Martin T. Baker, William A. Heriot